A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.

@article{Feld1985AMC,
  title={A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.},
  author={Ronald Feld and Thomas J. Louie and Lionel Mandell and Eric James Bow and Hope Robson and Angela Li-Ping Chow and Andrew Belch and Lil Miedzinski and Anita Rochelle Rachlis and Joseph L. Pater},
  journal={Archives of internal medicine},
  year={1985},
  volume={145 6},
  pages={1083-8}
}
During a multicenter prospective randomized trial in febrile neutropenic patients (neutrophil count, less than 1,000/cu mm), 103 episodes were treated with tobramycin sulfate plus ticarcillin disodium (TT) while 117 were treated with moxalactam plus ticarcillin disodium (MT). The majority of patients had an underlying diagnosis of leukemia (60%) and most (62.8%) had granulocyte counts of less than 100/cu mm at the start of therapy. The response rates for clinically or microbiologically… CONTINUE READING